Acq Bure
Acq Bure is a venture capital firm based in Stockholm, Sweden, focused on startups in Impact & Social Enterprise. This profile covers its focus and how founders can get in front of it in 2026.
Acq Bure is a acquisition company which raise capital through an IPO and within 36 months thereafter acquire an unlisted company.
- Investment focus
- Impact & Social Enterprise
- Location
- Stockholm, Sweden
How to pitch Acq Bure
The founders who hear back from Acq Bure lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Acq Bure
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Acq Bure." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/acq-bure
Frequently Asked Questions
What does Acq Bure invest in?
Acq Bure focuses on Impact & Social Enterprise. Match your sector and stage before reaching out, then find similar active investors on Round Funded.
Where is Acq Bure based?
Acq Bure is based in Stockholm, Sweden. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Acq Bure?
Unlock a verified email for Acq Bure and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.